Beli & Jual Diagnos Laboratorium Utama Tbk. - DGNS Hari Ini
Quarterly
Yearly
Income Statement
Revenue
Net Profit
Net Loss
Profit margin %
Q4
’24
Q1
’25
Q2
’25
Q3
’25
Q4
’25
| Item | Q4 2025 | Y/Y Change |
| Revenue | Rp166,62 M | +2.18% |
| Cost of Revenue | Rp87,86 M | -2.64% |
| Gross Profit | Rp78,77 M | +8.15% |
| General Expenses, Depreciation, Interest | Rp73,47 M | +3.66% |
| Operating Profit | Rp5,3 M | +170.31% |
| Other Income | Rp107,28 jt | -109.78% |
| EBT | Rp5,41 M | +525.9% |
| Taxes | -Rp2,47 M | +2022.76% |
| Net Income | Rp2,94 M | +292.95% |
Balance Sheet
Assets
Liabilities
Debt to Asset %
Q4
’24
Q1
’25
Q2
’25
Q3
’25
Q4
’25
| Item | Q4 2025 | Y/Y Change |
| Total Assets | Rp318,67 M | +6.22% |
| Total Liabilities | Rp114,68 M | +10.39% |
| Total Equity | Rp203,99 M | +4.01% |
| Total Liabilities & Total Equity | Rp318,67 M | +6.22% |
Cash Flow
Operating
Investing
Finance
Net CF
Q4
’24
Q1
’25
Q2
’25
Q3
’25
Q4
’25
| Item | Q4 2025 | Y/Y Change |
| CF from Operations | Rp10,66 M | -60.96% |
| CF from Investment | Rp9,23 M | -79.12% |
| CF from Financing | Rp2,83 M | -73.88% |
| Net Cash Flow | Rp4,27 M | -170.67% |